Literature DB >> 22591708

All-cause in-hospital mortality and comorbidity in diabetic and non-diabetic patients with stroke.

Karl F Braun1, Wolfgang Otter, Stefanie M Sandor, Eberhard Standl, Oliver Schnell.   

Abstract

INTRODUCTION: The aim of this study was to compare diabetic and non-diabetic patients with stroke with regard to their all-cause in-hospital mortality and possible differences regarding their comorbidities.
METHODS: All patients of the Munich Stroke Registry (2003-2004, n=537) were assessed. Hospital mortality in diabetic (n=160, 29.8%) and non-diabetic (n=377, 70.2%) patients was compared. Pre-existing comorbidities such as hypertension, coronary artery disease (CAD), peripheral arterial disease (PAD), albuminuria and impaired renal function (IRF) were noted.
RESULTS: Regarding all-cause in-hospital mortality, no significant differences were found between diabetic and non-diabetic patients. Overall 71 patients (13.2%) died of whom 27 (16.9%) where diabetic and 44 (11.7%) non-diabetic patients (n.s.). Hypertension, CAD, PAD, albuminuria and IRF were more frequent in diabetic patients (p<0.05).
CONCLUSION: Despite multiple comorbidities and risk factors no significant difference in all-cause in-hospital mortality was seen in diabetic patients as compared to non-diabetic patients. Improved treatment strategies and early intervention may compensate for their poorer prognosis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22591708     DOI: 10.1016/j.diabres.2012.04.016

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Acute ischemic stroke patients with diabetes should not be excluded from intravenous thrombolysis.

Authors:  Blanca Fuentes; Andrés Cruz-Herranz; Patricia Martínez-Sánchez; Ana Rodríguez-Sanz; Gerardo Ruiz Ares; Daniel Prefasi; Borja E Sanz-Cuesta; Manuel Lara-Lara; Exuperio Díez-Tejedor
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

Review 2.  Why primary obesity is a disease?

Authors:  Antonino De Lorenzo; Santo Gratteri; Paola Gualtieri; Andrea Cammarano; Pierfrancesco Bertucci; Laura Di Renzo
Journal:  J Transl Med       Date:  2019-05-22       Impact factor: 5.531

3.  The telestroke and thrombolysis therapy in diabetic stroke patients.

Authors:  Thomas I Nathaniel; Chibueze Ubah; Leah Wormack; Jordan Gainey
Journal:  Diabetol Metab Syndr       Date:  2019-05-09       Impact factor: 3.320

Review 4.  Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review.

Authors:  Lik-Hui Lau; Jeremy Lew; Karen Borschmann; Vincent Thijs; Elif I Ekinci
Journal:  J Diabetes Investig       Date:  2018-10-13       Impact factor: 4.232

5.  Impact of Diabetes on Complications, Long Term Mortality and Recurrence in 608,890 Hospitalised Patients with Stroke.

Authors:  Weronika A Szlachetka; Tiberiu A Pana; Somsak Tiamkao; Allan B Clark; Kannikar Kongbunkiat; Kittisak Sawanyawisuth; Joao H Bettencourt-Silva; Narongrit Kasemap; Mamas A Mamas; Phyo K Myint
Journal:  Glob Heart       Date:  2020-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.